Norepinephrine salt formulations are not a matter of pharmacologic potency

被引：1
|
作者：
Wieruszewski, Patrick M. [1 ,2 ]
Khanna, Ashish K. [3 ,4 ]
机构：
[1] Mayo Clin, Dept Pharm, RO MB GR 722PH,200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Anesthesiol, Rochester, MN 55902 USA
[3] Wake Forest Univ, Dept Anesthesiol, Sect Crit Care Med, Sch Med,Atrium Hlth Wake Forest Baptist Med Ctr, Winston Salem, NC USA
[4] Outcomes Res Consortium, Cleveland, OH USA
来源：
INTENSIVE CARE MEDICINE | 2024年 / 50卷 / 07期
关键词：
D O I：
10.1007/s00134-024-07451-2
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1179 / 1180
页数：2
相关论文
共 50 条
  • [1] Norepinephrine Salt Formulations and Risk of Therapeutic Error: Results of a National Survey
    Salvati, Stefano
    Ursoleo, Jacopo D'Andria
    Belletti, Alessandro
    Monti, Giacomo
    Bonizzoni, Matteo Aldo
    Fazio, Maria
    Landoni, Giovanni
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (11) : 2624 - 2629
  • [2] The Potency of Different Propofol Formulations
    Goddon, Sven
    ANESTHESIOLOGY, 2014, 121 (03) : 663 - 664
  • [3] ANTIFEEDING POTENCY OF NEEM FORMULATIONS
    REDFERN, RE
    WARTHEN, JD
    JACOBSON, M
    STOKES, JB
    JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-ENVIRONMENTAL SCIENCE AND ENGINEERING & TOXIC AND HAZARDOUS SUBSTANCE CONTROL, 1984, 19 (04): : 477 - 481
  • [4] Determining potency of preclinical dose formulations
    Sanchez, Ashley
    Whitsel, Melissa
    Smith, Amy
    Pharmaceutical Technology, 2012, 36 (10) : 132 - 134
  • [5] The Potency of Different Propofol Formulations Reply
    Le Guen, Morgan
    Fischler, Marc
    ANESTHESIOLOGY, 2014, 121 (03) : 664 - 664
  • [6] Pharmacologic and Pharmacodynamic Equivalence of 2 Formulations of Orlistat
    Johnson, Steven
    Schwartz, Susan M.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (07): : 773 - 780
  • [7] Bioassay to Determine the Potency of Miconazole in Pharmaceutical Formulations
    Guidolin, Larissa
    Almeida, Leticia L. M.
    Esmerino, Luis A.
    Barboza, Fernanda M.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (04): : 748 - 752
  • [8] Fluid Formulations Matter
    不详
    MANUFACTURING ENGINEERING, 2011, 147 (03): : 38 - 39
  • [9] HEISENBERG CONCEPT OF MATTER AS POTENCY
    CARELLA, MJ
    DIOGENES, 1976, (96) : 25 - 37
  • [10] COMPARISON OF 3 FORMULATIONS OF METOLAZONE - BIOAVAILABILITY AND PHARMACOLOGIC EFFECTS
    MILLER, RP
    WOODWORTH, JR
    GRAVES, DA
    LOCKE, CS
    STEIGER, BW
    ROTENBERG, KS
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1988, 43 (06): : 1133 - 1142
12345